Neoplasm malignant
Not recruitingA Study of GEN1047 in Patients with Solid Tumors: First Time Use in Humans
- Disease:Neoplasm malignant
- Substances:Gen1047
France- Participants:18–64 years · 65+ years
- Substances:Gen1047
- Sponsor:Genmab A/S
Rare diseases
Investigational molecules
Locations
Back to France619 clinical trials in Poitiers, France across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in FranceEssaisCliniques.fr(opens in a new tab)
France
France
France
France
France
France
France
France
France
France
France
FranceThe busiest research cities in the country
What the registry says about research in the country
Innovative clinical trials focusing on multiple myeloma, colorectal cancer, and various advanced cancers. Studies are evaluating novel therapeutic combinations and treatment strategies for better patient outcomes.
Several trials are investigating targeted therapies and immunotherapy approaches for various cancer types.
Research focusing on essential tremor treatments and innovative therapeutic approaches. Clinical trials are evaluating new medications for movement disorders.
Studies aim to improve patient quality of life through novel therapeutic interventions.
Advanced research in kidney transplantation and post-transplant care, including studies on antibody-mediated rejection prevention and treatment strategies.
Trials focus on improving long-term outcomes for transplant recipients.
Studies evaluating postoperative care and pain management in critical care settings, including innovative approaches to patient comfort and recovery.
Research aims to enhance patient comfort and recovery in intensive care settings.
Tell us about your condition – we search every trial in Europe and connect you with the right site.